Severe Acute Respiratory Syndrome Coronavirus 2

Showing 1 - 25 of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID 19 Disease, Mild to Moderate COVID 19 Disease, SARS-CoV-2 Trial (Tafenoquine Oral Tablet, Placebo)

Not yet recruiting
  • COVID 19 Disease
  • +4 more
  • Tafenoquine Oral Tablet
  • Placebo
  • (no location specified)
Jul 13, 2023

Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Bobo-Dioulasso, Conakry (Nitazoxanide

Recruiting
  • Covid19
  • +3 more
  • Nitazoxanide and Ciclésonide
  • +3 more
  • Bobo-Dioulasso, Burkina Faso
  • +1 more
Jan 30, 2023

Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Ferrara (SARS-Cov-2 infection)

Recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • SARS-Cov-2 infection
  • Ferrara, Italy
    Azienda Ospedaliera Universitaria di Ferrara
Nov 1, 2022

SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial (Bivalent BNT162b2 (original/Omicron

Not yet recruiting
  • SARS-CoV-2 Virus
  • +2 more
  • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
  • +4 more
  • (no location specified)
Sep 14, 2022

Pulmonary Fibrosis During Severe COVID-19 Pneumonia

Active, not recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • +2 more
  • Aminoterminal type III peptide of procollagen
  • Lung computed tomography
  • Marseille, France
    Hopital Europeen Marseille
Aug 7, 2022

Severe Acute Respiratory Syndrome Coronavirus 2 Trial (COVAC-2, Saline Placebo)

Not yet recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • COVAC-2
  • Saline Placebo
  • (no location specified)
Aug 5, 2022

Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Halifax, Saskatoon (COVAC-2, Saline Placebo)

Active, not recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • COVAC-2
  • Saline Placebo
  • Halifax, Nova Scotia, Canada
  • +1 more
Aug 5, 2022

Severe Acute Respiratory Syndrome Coronavirus 2, Aspergillosis Invasive Trial in Orange, Sacramento, San Diego (Isavuconazonium

Terminated
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • Aspergillosis Invasive
  • Isavuconazonium Injection [Cresemba]
  • Placebo
  • Orange, California
  • +2 more
Jul 26, 2022

COVID-19, SARS-CoV 2, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in San Francisco (Oral-B Mouth Sore mouthwash, Crest

Recruiting
  • COVID-19
  • +5 more
  • Oral-B Mouth Sore mouthwash
  • +4 more
  • San Francisco, California
    University Of California, San Francisco
May 17, 2022

COVID, Covid-19, Coronavirus Trial in Brazil, United States (APL-9, Vehicle Control)

Completed
  • COVID
  • +8 more
  • Fresno, California
  • +23 more
Mar 21, 2022

Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial in Worldwide (SNG001, Placebo)

Completed
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • COVID-19
  • Tucson, Arizona
  • +111 more
Mar 2, 2022

Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Worldwide (Anti-Sars-CoV-2 Convalescent Plasma)

No longer available
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • Anti-Sars-CoV-2 Convalescent Plasma
  • Oceanside, California
  • +37 more
Feb 16, 2022

Severe Acute Respiratory Syndrome Coronavirus 2, Severe Acute Respiratory Distress Syndrome Trial in Paris (Umbilical cord

Completed
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • Severe Acute Respiratory Distress Syndrome
  • Umbilical cord Wharton's jelly-derived human
  • NaCl 0.9%
  • Paris, France
  • +1 more
Feb 17, 2022

Coronavirus Infection, Severe Acute Respiratory Infection, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in United

Recruiting
  • Coronavirus Infection
  • +2 more
  • Drug: NA-831
  • +3 more
  • Los Angeles, California
  • +30 more
Jan 31, 2022

Stratification With Chest CT to Rule-out Suspected SARS-CoV-2

Completed
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • CT-imaging
  • Jena, Thuringia, Germany
    Jena University Hospital
Sep 17, 2021

Beaumont Health Large-scale Automated Serologic Testing for

Completed
  • COVID-19
  • +2 more
  • EUROIMMUN assay
  • Royal Oak, Michigan
  • +1 more
Sep 2, 2021

Health and Infection Control Practices Among Dentists

Completed
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • No intervention
  • Chicago, Illinois
    American Dental Association
Jul 20, 2021

Prone Positioning and Regional Ventilation in Mechanically

Completed
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • +2 more
  • Prone positioning
  • Geneva, Switzerland
    University Hospitals of Geneva
Jul 20, 2021

COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Huixquilucan (Ruxolitinib Oral Tablet)

Completed
  • COVID-19
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • Ruxolitinib Oral Tablet
  • Huixquilucan, Estado De México, Mexico
    Grupo Cooperativo de Hemopatías Malignas
Jul 5, 2021

Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Zárate (Transcutaneous Auricular Vagus Nerve Stimulation)

Completed
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • Transcutaneous Auricular Vagus Nerve Stimulation
  • Zárate, Buenos Aires, Argentina
    Hospital Zonal Virgen del Carmen de Zárate
Jun 1, 2021

COVID 19, Coronavirus, Diabetes, Type 2 Trial in Be'er Ya'aqov, Petah tikva (Linagliptin 5 MG)

Terminated
  • COVID 19
  • +14 more
  • Linagliptin 5 MG
  • Be'er Ya'aqov, Israel
  • +2 more
May 28, 2021

Communication in ICU During COVID-19

Completed
  • COVID-19
  • +2 more
  • Communication
  • Dubai, United Arab Emirates
    NMC Specialty Hospital
May 9, 2021

Severe Acute Respiratory Syndrome Coronavirus 2, Coronavirus Infection, Mild to Moderate COVID-19 Trial in Seoul (Fluvoxamine,

Suspended
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • +2 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 14, 2021

Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 Trial in Sao Paulo (Janus Kinase Inhibitor (ruxolitinib), Placebo)

Terminated
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • SARS-CoV2
  • Janus Kinase Inhibitor (ruxolitinib)
  • Placebo
  • Sao Paulo, Brazil
    Hospital das Clínicas
Apr 5, 2021

Severe Acute Respiratory Syndrome Coronavirus 2, Metabolic Syndrome, Type 2 Diabetes Trial in Mexico City (metformin glycinate,

Withdrawn
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • +2 more
  • metformin glycinate
  • Placebo oral tablet
  • Mexico City, Mexico
    Hospital Juárez de México, OPD
Apr 5, 2021